trending Market Intelligence /marketintelligence/en/news-insights/trending/RGgq2Y7ABPFVjLeXQAR3fw2 content esgSubNav
In This List

Liquidia Technologies closes $31.7M common stock offering

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Liquidia Technologies closes $31.7M common stock offering

Liquidia Technologies Inc. completed an underwritten public offering of 3 million common shares to raise about $31.7 million in net proceeds.

The Morrisville, N.C.-based biopharmaceutical company priced the shares at $11.50 each and gave underwriters an option to buy up to an additional 450,000 shares.

Jefferies and Cowen were joint book-running managers, while Needham & Co. and Wedbush PacGrow were co-managers for the offering.

Liquidia develops human therapeutics using its proprietary print technology, a particle engineering platform. Its lead product candidate LIQ861 — an inhaled dry powder formulation of treprostinil — is in a phase 3 study to treat pulmonary arterial hypertension.